31/05/2024  8:07:46 Diferencia -0.4500 Volumen Bid21:56:32 Ask21:56:32 Capitalización de mecado Dividendo A. P/E Ratio
182.8500EUR -0.25% 0
Volumen de negocios: 0.0000
-Volumen de oferta: - -Tamaño/ Volumen/ Formato de Ask: - 16.84 mil millonesEUR 0.38% 54.36

Descripción de negocio

Sartorius Stedim Biotech is a leading international supplier of products and services that enable the biopharmaceutical industry to develop and manufacture drugs safely and efficiently. As a total solutions provider, Sartorius Stedim Biotech offers a portfolio covering nearly all steps of biopharmaceutical manufacture. The company focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Headquartered in Aubagne, France, Sartorius Stedim Biotech is quoted on the Eurolist of Euronext Paris. With its own manufacturing and R&D sites in Europe, North America and Asia and an international network of sales companies, Sartorius Stedim Biotech has a global reach.
 

Consejo de gestión & Consejo de supervisión

CEO
Dr. Joachim Kreuzburg
Consejo de gestión
Alexandra Gatzemeyer, Dr. René Fáber
Consejo de supervisión
Joachim Kreuzburg, René Fáber, Pascale Boissel, Susan Dexter, Romaine Fernandes, Anne-Marie Graffin, Lothar Kappich, Henri Riey
 

Datos de la empresa

Nombre: Sartorius Stedim Biotech SA
Dirección: Avenue de Jouques - CS 91051,F-13781 Aubagne Cedex
Teléfono: +33-442-84-5600
Fax: +33-442-84-5619
E-mail: info@sartorius-stedim.com
Internet: https://www.sartorius.com/en/company/about-sartorius-stedim-biotech-sa
Industria: Biotechnology
Sector: Biotechnology
Subsector: Biotechnology
Fin del año financiero: 31/12
Acciones de libre circulación: 26.20%
Fecha de OPI: -

Relación con inversores

Nombre: Petra Kirchhoff
IR teléfono: +49-551-308-1686
IR-fax: -
IR e-mail: petra.kirchhoff@sartorius.com

Calendario de la empresa

CW 29 | 19/07/2024 Interim Report 2nd Quarter/6 Months
CW 42 | 17/10/2024 Interim Report 3rd Quarter/9 Months
 

Accionistas mayoritarios

Sartorius AG
 
73.60%
free float
 
26.40%